RBC Capital cuts price targets on Sylvamo and EyePoint
RBC Capital cut its price target on Sylvamo to $35 from $46 and on EyePoint to $1 from $5, keeping Sector Perform ratings on both stocks.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Analysts at RBC Capital lowered their price target on Sylvamo shares to $35 from $46. The rating stayed at Sector Perform, which is a neutral stance. The information was reported by Dow Jones Newswires, citing Benzinga.
The same bank reduced its price target on EyePoint from $5 to $1 and also kept a Sector Perform rating. Both changes appeared in a ratings roundup published on October 20, 2026.
why it matters
Price target adjustments like these usually reflect a revision to the company's valuation model and rarely move the broader market on their own. The EyePoint cut is much sharper, since the target fell fivefold, while the Sylvamo cut is roughly a quarter of its previous level. Both stocks keep neutral ratings.
tags
instruments
sources
- Sylvamo Price Target Cut to $35.00/Share From $46.00 by RBC Capital — Dow Jones Newswires, 20 October 2026 at 10:29 UTC
- EyePoint Price Target Cut to $1.00/Share From $5.00 by RBC Capital — Dow Jones Newswires, 20 October 2026 at 13:29 UTC
- argenx Price Target Cut to $1025.00/Share From $1100.00 by RBC Capital — Dow Jones Newswires, 20 October 2026 at 13:47 UTC
- Gildan Activewear Price Target Cut to $70.00/Share From $82.00 by RBC Capital — Dow Jones Newswires, 20 October 2026 at 14:08 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗